Jpmorgan Chase & Co »

Halozyme Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2012-06-30 $14M 1.6M 8.87
2010-12-31 $12M 1.6M 7.92

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Halozyme Therapeutics

Vanguard Group
Artisan Partners Limited Partnership
Alliancebernstein
Jpmorgan Chase & Co
Jennifer Ranahan
TD Asset Management
Charles Schwab Investment Management
Dimensional Fund Advisors
Arrowpoint Asset Management
Goldman Sachs Group
T. Rowe Price Associates
Norges Bank Investment Management
Bank of New York Mellon
Bank of America Corporation
New York State Common Retirement Fund

View all funds holding Halozyme Therapeutics